CN116096361B - 新型环烯酮化合物或其盐 - Google Patents
新型环烯酮化合物或其盐Info
- Publication number
- CN116096361B CN116096361B CN202180057124.1A CN202180057124A CN116096361B CN 116096361 B CN116096361 B CN 116096361B CN 202180057124 A CN202180057124 A CN 202180057124A CN 116096361 B CN116096361 B CN 116096361B
- Authority
- CN
- China
- Prior art keywords
- compound
- added
- mixture
- methyl group
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020-135328 | 2020-08-07 | ||
| JP2020135328 | 2020-08-07 | ||
| PCT/JP2021/029246 WO2022030606A1 (ja) | 2020-08-07 | 2021-08-06 | 新規なシクロアルケノン化合物又はその塩 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116096361A CN116096361A (zh) | 2023-05-09 |
| CN116096361B true CN116096361B (zh) | 2025-10-10 |
Family
ID=80118163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180057124.1A Active CN116096361B (zh) | 2020-08-07 | 2021-08-06 | 新型环烯酮化合物或其盐 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230295068A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4194435A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7109705B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102974166B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116096361B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021321705B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023001832A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3188292A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023001536A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI829001B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022030606A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023153422A1 (ja) * | 2022-02-09 | 2023-08-17 | 大鵬薬品工業株式会社 | シクロヘキセノン化合物の結晶形 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6228893B1 (en) * | 1997-08-13 | 2001-05-08 | Meiji Milk Products Co., Ltd. | Cyclohexenone long-chain alcohol and medicament containing same |
| US20040132829A1 (en) * | 2001-02-19 | 2004-07-08 | Masao Miyagawa | Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009111576A2 (en) * | 2008-03-05 | 2009-09-11 | Edison Pharmaceuticals, Inc. | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
| TWI501968B (zh) * | 2010-11-12 | 2015-10-01 | Merck Sharp & Dohme | 六氫吡啶酮甲醯胺氮雜茚滿cgrp受體拮抗劑 |
| CA2883879A1 (en) * | 2012-09-07 | 2014-03-13 | Edison Pharmaceuticals, Inc. | Quinone derivatives for use in the modulation of redox status of individuals |
| EP3389646A1 (en) * | 2015-12-17 | 2018-10-24 | BioElectron Technology Corporation | Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
| RU2729186C2 (ru) | 2016-01-22 | 2020-08-05 | Тайхо Фармасьютикал Ко., Лтд. | Способ производства длинноцепочечного спирта циклогексенона высокой степени очистки |
| TWI831738B (zh) * | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物 |
-
2021
- 2021-08-06 CN CN202180057124.1A patent/CN116096361B/zh active Active
- 2021-08-06 MX MX2023001536A patent/MX2023001536A/es unknown
- 2021-08-06 TW TW110129168A patent/TWI829001B/zh active
- 2021-08-06 EP EP21853226.5A patent/EP4194435A4/en active Pending
- 2021-08-06 CA CA3188292A patent/CA3188292A1/en active Pending
- 2021-08-06 WO PCT/JP2021/029246 patent/WO2022030606A1/ja not_active Ceased
- 2021-08-06 US US18/040,862 patent/US20230295068A1/en active Pending
- 2021-08-06 AU AU2021321705A patent/AU2021321705B2/en active Active
- 2021-08-06 BR BR112023001832A patent/BR112023001832A2/pt unknown
- 2021-08-06 KR KR1020237006213A patent/KR102974166B1/ko active Active
- 2021-08-06 JP JP2022518890A patent/JP7109705B2/ja active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6228893B1 (en) * | 1997-08-13 | 2001-05-08 | Meiji Milk Products Co., Ltd. | Cyclohexenone long-chain alcohol and medicament containing same |
| US20040132829A1 (en) * | 2001-02-19 | 2004-07-08 | Masao Miyagawa | Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria |
Non-Patent Citations (1)
| Title |
|---|
| Ming Chang P. Yeh et al..1,4-Additions of the Highly functionalized Copper Reagents RCu(CN)ZnI•2 BF3 to Trisubstituted Enones: A New BF3 Promoted Cyclization Reaction.《Nanoscale Research Letters》.1988,第29卷(第51期),第6693-6696页,尤其是第6694页合成路线2. * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202216650A (zh) | 2022-05-01 |
| CA3188292A1 (en) | 2022-02-10 |
| JP7109705B2 (ja) | 2022-07-29 |
| KR20230043923A (ko) | 2023-03-31 |
| EP4194435A1 (en) | 2023-06-14 |
| US20230295068A1 (en) | 2023-09-21 |
| JPWO2022030606A1 (cg-RX-API-DMAC7.html) | 2022-02-10 |
| WO2022030606A1 (ja) | 2022-02-10 |
| KR102974166B1 (ko) | 2026-06-09 |
| BR112023001832A2 (pt) | 2023-02-23 |
| TWI829001B (zh) | 2024-01-11 |
| EP4194435A4 (en) | 2024-09-25 |
| AU2021321705A1 (en) | 2023-03-09 |
| CN116096361A (zh) | 2023-05-09 |
| AU2021321705B2 (en) | 2024-02-29 |
| MX2023001536A (es) | 2023-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2844637B1 (en) | Substituted 3-haloallylamine inhibitors of ssao and uses thereof | |
| CN110128432B (zh) | 含氮三环化合物及其在药物中的应用 | |
| WO2024032747A1 (zh) | 三环类化合物及其医药用途 | |
| TWI690511B (zh) | 用於治療疾病之葡萄糖苷基腦醯胺(glucosylceramide)合成酶抑制劑 | |
| CN102958937B (zh) | 作为磷酸二酯酶抑制剂的苯并二氧杂环戊烯或苯并二氧杂环庚烯杂环化合物 | |
| JP4115105B2 (ja) | ピラゾール誘導体 | |
| EP3153511B1 (en) | 2-acylaminothiazole derivative for use in the prevention or treatment of bladder/urinary tract diseases | |
| CZ20033296A3 (cs) | Benzoylsulfonamidy a sulfonylbenzamidiny jako protinádorové sloučeniny | |
| WO2019149228A1 (zh) | 取代咪唑甲酸酯类衍生物及其用途 | |
| EP3348548A1 (en) | Nitric oxide-releasing prodrug molecule | |
| US20260137676A1 (en) | Piperazine substituted phenol derivative and use thereof | |
| CN116096361A (zh) | 新型环烯酮化合物或其盐 | |
| US12274694B2 (en) | Dizocilpine derivatives as peripheral NMDA receptor antagonists | |
| CN112243437A (zh) | 含丙烯酰基的核转运调节剂及其用途 | |
| TW202604902A (zh) | 作為電壓閘控鈉通道抑制劑的化合物及其應用 | |
| HK40087434B (en) | Novel cycloalkenone compound or salt thereof | |
| HK40087434A (zh) | 新型环烯酮化合物或其盐 | |
| CN113149894B (zh) | (e)-3-芳杂环基丙-2-烯酸衍生物的制药用途 | |
| US12030835B2 (en) | Substituted amide compounds useful as farnesoid X receptor modulators | |
| CN114957270A (zh) | 一种s(+)-普拉洛芬衍生物及其制备方法与用途 | |
| CN111138422B (zh) | 一种用于防治红斑狼疮的药物及其制备方法 | |
| CN111233837A (zh) | 一种缩氨基硫脲的化合物及其制备方法和用途 | |
| CN119059989A (zh) | Urat1抑制剂及其制备方法和用途 | |
| JPS6219430B2 (cg-RX-API-DMAC7.html) | ||
| HK1203477B (en) | Substituted 3-haloallylamine inhibitors of ssao and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40087434 Country of ref document: HK |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |